CEO Daniel Scavilla was paid $8,760,139 in fiscal year 2025, the 32nd percentile of its disclosed peer group (SEC filing 0000818479-26-000125 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$10,814,258 Simon Campion total, FY2025 Former President and Chief Executive Officer — highest-paid officer; CEO Daniel Scavilla: $8,760,139 | 32nd CEO (Daniel Scavilla) pay percentile vs peers | 184:1 CEO-to-median pay ratio | 94.58% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
XRAY's next annual pay disclosure, estimated May 7, 2027.est. Filing ↗
Page 2 of 24 of the DENTSPLY SIRONA Inc. Executive Compensation Report, as it is delivered: Executive Summary.
That is page 2 of 24 of the full Executive Compensation Report, shown as it is delivered. The rest:
Every figure above cites the filing it came from (accession 0000818479-26-000125, filed 2026-10-02) — see the source register, §11.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Simon Campion | $598,247 | $0 | $4,592,309 | $4,371,687 | $493,553 | $0 | $758,462 | $10,814,258 |
| Former President and Chief Executive Officer | ||||||||
| Daniel Scavilla | 431,753 | 1,079,315 | 3,484,488 | 3,221,523 | 437,150 | 0 | 105,910 | 8,760,139 |
| President and Chief Executive Officer | ||||||||
| Robert Johnson | 572,410 | 0 | 1,417,236 | 3,363,612 | 268,913 | 0 | 84,692 | 5,706,863 |
| Senior Vice President, Chief Supply Chain Officer | ||||||||
| Richard Rosenzweig | 452,727 | 0 | 1,366,619 | 1,311,618 | 300,128 | 0 | 1,262,588 | 4,693,681 |
| Former Executive Vice President, Corporate Development, General Counsel and Secretary | ||||||||
| Matthew Garth | 350,685 | 0 | 2,118,608 | 676,116 | 0 | 0 | 648,949 | 3,794,358 |
| Former Executive Vice President, Chief Financial Officer | ||||||||
| Andrea Frohning | 481,043 | 0 | 809,858 | 777,380 | 225,462 | 0 | 69,215 | 2,362,959 |
| Senior Vice President, Chief Human Resources Officer | ||||||||
| Aldo Denti | 188,301 | 1,150,000 | 0 | 0 | 160,056 | 0 | 9,480 | 1,507,838 |
| Executive Vice President, Chief Commercial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Simon Campion | $10,814,258 | $8,683,952 | $8,518,987 | ↑ +2,130,306 |
| Daniel Scavilla | 8,760,139 | — | — | — |
| Robert Johnson | 5,706,863 | 2,228,161 | 2,937,759 | ↑ +3,478,702 |
| Richard Rosenzweig | 4,693,681 | 2,506,351 | 4,354,002 | ↑ +2,187,330 |
| Matthew Garth | 3,794,358 | — | — | — |
| Andrea Frohning | 2,362,959 | — | — | — |
| Aldo Denti | 1,507,838 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read DENTSPLY SIRONA Inc.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper XRAY reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the DENTSPLY SIRONA Inc. Peer Teardown Report
$10,814,258 Simon Campion total, FY2025
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of October 2, 2026 · Source: 0000818479-26-000125 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for XRAY
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order XRAY
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
The list of companies that name XRAY as a peer is temporarily unavailable — recheck shortly.
Get the DENTSPLY SIRONA Inc. Executive Compensation Report
$1,500
One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.
| Executive | Role | FY2025 total |
|---|---|---|
| Aldo Denti | CCO | $1,507,838 |
| Daniel Scavilla | CEO | $8,760,139 |
| Richard Rosenzweig | General Counsel | $4,693,681 |
| Andrea Frohning | Executive | $2,362,959 |
| Robert Johnson | SVP | $5,706,863 |
| Matthew Garth | CFO | $3,794,358 |
| Simon Campion | Executive | $10,814,258 |
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Betsy D. Holden | Independent Director | $335,000 |
| Brian P. McKeon | Independent Director | — |
| Brian T. Gladden | Independent Director | $320,000 |
| Clyde R. Hosein | Independent Director | $320,000 |
| Donald J. Zurbay | Independent Director | — |
| Dorothea Wenzel | Former director (through FY2025) | — |
| Gregory T. Lucier | Chair of the Board | $595,000 |
| James D. Forbes | Independent Director | — |
| Janet S. Vergis | Independent Director | $335,000 |
| Jonathan J. Mazelsky | Independent Director | $330,000 |
| Leslie F. Varon | Independent Director | $345,000 |
| Michael J. Barber | Independent Director | $335,278 |
| Willie A. Deese | Former director (through FY2025) | $325,000 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Daniel T. Scavilla | Director | 2026-05-22 | D | 4,095 | $10 | $41,810 | Common | Form 4 ↗ |
| Brian P. McKeon | Director | 2026-06-03 | A | 28,887 | 0 | 0 | Common | Form 4 ↗ |
| Janet S. Vergis | Director | 2026-06-03 | A | 22,822 | 0 | 0 | Common | Form 4 ↗ |
| Gregory T. Lucier | Director | 2026-06-03 | A | 10,900 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Gregory T. Lucier | Director | 2026-06-03 | A | 38,382 | 0 | 0 | Common | Form 4 ↗ |
| Betsy D. Holden | Director | 2026-06-03 | A | 22,822 | 0 | 0 | Common | Form 4 ↗ |
| Michael J. Barber | Director | 2026-06-03 | A | 22,822 | 0 | 0 | Common | Form 4 ↗ |
| James D. Forbes | Director | 2026-06-03 | A | 28,887 | 0 | 0 | Common | Form 4 ↗ |
| Brian T. Gladden | Director | 2026-06-03 | A | 22,822 | 0 | 0 | Common | Form 4 ↗ |
| Clyde R. Hosein | Director | 2026-06-03 | A | 22,822 | 0 | 0 | Common | Form 4 ↗ |
| Leslie F. Varon | Director | 2026-06-03 | A | 22,822 | 0 | 0 | Common | Form 4 ↗ |
| Donald J. Zurbay | Director | 2026-06-03 | A | 22,822 | 0 | 0 | Common | Form 4 ↗ |
| Gregory T. Lucier | Director | 2026-06-03 | D | 10,900 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Gregory T. Lucier | Director | 2026-06-03 | A | 10,900 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Gregory T. Lucier | Director | 2026-06-03 | A | 38,382 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Jonathan J. Mazelsky | Director | 2026-06-03 | A | 22,822 | 0 | 0 | Common | Form 4 ↗ |
| Gregory T. Lucier | Director | 2026-06-03 | D | 38,382 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Michael J. Barber | Director | 2026-06-11 | A | 15,175 | 10 | 150,005 | Common | Form 4 ↗ |
| Betsy D. Holden | Director | 2026-06-11 | A | 10,086 | 10 | 99,692 | Common | Form 4 ↗ |
| Jonathan J. Mazelsky | Director | 2026-06-12 | A | 10,000 | 10 | 101,400 | Common | Form 4 ↗ |
| Jonathan J. Mazelsky | Director | 2026-06-12 | A | 10,000 | 10 | 101,400 | Common | Form 4 ↗ |
| Brian P. McKeon | Director | 2026-06-12 | A | 10,000 | 10 | 101,200 | Common | Form 4 ↗ |
| Clyde R. Hosein | Director | 2026-06-15 | A | 6,500 | 10 | 64,903 | Common | Form 4 ↗ |
| Brian T. Gladden | Director | 2026-06-15 | A | 9,985.02 | 10 | 100,000 | Common | Form 4 ↗ |
| Jonathan J. Mazelsky | Director | 2026-06-30 | A | 2,841.83 | 11 | 30,010 | Derivative, Class A Common | Form 4 ↗ |
| Andrea Frohning | SVP, CHRO | 2026-08-07 | D | 802 | 12 | 9,720 | Common | Form 4 ↗ |
| John C. Fortson | EVP & CFO | 2026-08-10 | A | 104,200 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John C. Fortson | EVP & CFO | 2026-08-10 | A | 24,014 | 0 | 0 | Common | Form 4 ↗ |
| Jonathan J. Mazelsky | Director | 2026-09-30 | A | 3,323.43 | 9 | 30,011 | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Robert Johnson | PSU | 2025-03-03 | — | 26,267 | — | 857,234 | $105,066 |
| Andrea Frohning | PSU | 2025-03-03 | 15,010 | 30,019 | — | 60,038 | 489,850 |
| Andrea Frohning | RSU | 2025-03-03 | — | — | 20,013 | — | 320,008 |
| Simon Campion | OPTION | 2025-03-03 | — | — | 1,166,900 | — | 4,371,687 |
| Simon Campion | PSU | 2025-03-03 | 140,713 | 281,426 | — | 562,852 | 4,592,309 |
| Matthew Garth | RSU | 2025-05-30 | — | — | 43,023 | — | 687,508 |
| Matthew Garth | PSU | 2025-05-30 | 43,023 | 86,045 | — | 172,090 | 1,431,100 |
| Richard Rosenzweig | PSU | 2025-03-03 | 25,329 | 50,657 | — | 101,314 | 826,620 |
| One-Time Equity | PSU | 2025-08-08 | — | 123,457 | — | 3,200,005 | 493,828 |
| Richard Rosenzweig | RSU | 2025-03-03 | — | — | 33,771 | — | 539,998 |
| Richard Rosenzweig | OPTION | 2025-03-03 | — | — | 350,100 | — | 1,311,618 |
| Andrea Frohning | OPTION | 2025-03-03 | — | — | 207,500 | — | 777,380 |
| Matthew Garth | OPTION | 2025-05-30 | — | — | 173,800 | — | 676,116 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Robert Johnson | $0 | $105,066 | $0 | 100.0% |
| Andrea Frohning | 320,008 | 489,850 | 777,380 | 30.9% |
| Simon Campion | 0 | 4,592,309 | 4,371,687 | 51.2% |
| Matthew Garth | 687,508 | 1,431,100 | 676,116 | 51.2% |
| Richard Rosenzweig | 539,998 | 826,620 | 1,311,618 | 30.9% |
| One-Time Equity | 0 | 493,828 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Robert Johnson | RSU | 3,614 | — | $41,304 |
| Simon Campion | RSU | 25,865 | — | 295,632 |
| Robert Johnson | Option | 21,733 | 33.28 | — |
| Daniel Scavilla | PSU | 17,699 | — | 202,296 |
| Simon Campion | RSU | 9,235 | — | 105,560 |
| Richard Rosenzweig | RSU | 41,901 | — | 478,931 |
| Richard Rosenzweig | RSU | 33,501 | — | 386,299 |
| Robert Johnson | RSU | 16,573 | — | 189,428 |
| Simon Campion | RSU | 51,398 | — | 587,483 |
| Andrea Frohning | RSU | 3,335 | — | 38,117 |
| Andrea Frohning | Option | 15,066 | 33.28 | — |
| Richard Rosenzweig | RSU | 13,895 | — | 158,823 |
| Robert Johnson | RSU | 43,452 | — | 496,658 |
| Andrea Frohning | RSU | 11,474 | — | 131,151 |
| Matthew Garth | RSU | 9,780 | — | 111,788 |
| Daniel Scavilla | RSU | 1,102,600 | — | 12,602,496 |
| Daniel Scavilla | RSU | 250,074 | — | 2,858,352 |
| Robert Johnson | RSU | 6,905 | — | 78,925 |
| Simon Campion | RSU | 142,757 | — | 1,631,708 |
| Andrea Frohning | RSU | 20,692 | — | 236,511 |
| Robert Johnson | RSU | 14,453 | — | 165,202 |
| Simon Campion | RSU | 36,942 | — | 422,249 |
| Richard Rosenzweig | RSU | 4,940 | — | 56,459 |
| Daniel Scavilla | Option | 1,102,600 | 12.96 | — |
| Robert Johnson | RSU | 36,834 | — | 421,014 |
| Andrea Frohning | Option | 207,500 | 15.99 | — |
| Robert Johnson | RSU | 36,210 | — | 413,886 |
| Andrea Frohning | RSU | 13,340 | — | 152,481 |
| Richard Rosenzweig | RSU | 34,917 | — | 399,102 |
| Robert Johnson | Option | 8,633 | 38.74 | — |
| Andrea Frohning | RSU | 24,830 | — | 283,806 |
| Richard Rosenzweig | RSU | 3,590 | — | 41,030 |
| Andrea Frohning | RSU | 23,868 | — | 230,732 |
| Richard Rosenzweig | RSU | 19,760 | — | 225,858 |
| Richard Rosenzweig | RSU | 17,233 | — | 196,968 |
| Daniel Scavilla | RSU | 14,199 | — | 162,293 |
| Simon Campion | RSU | 12,850 | — | 146,876 |
| Andrea Frohning | RSU | 2,868 | — | 32,782 |
| Matthew Garth | RSU | 12,225 | — | 139,734 |
| Robert Johnson | RSU | 10,864 | — | 124,170 |
| Richard Rosenzweig | RSU | 10,475 | — | 119,727 |
| Richard Rosenzweig | RSU | 8,233 | — | 94,106 |
| Simon Campion | RSU | 6,466 | — | 73,908 |
| Andrea Frohning | RSU | 6,208 | — | 70,955 |
| Andrea Frohning | RSU | 4,781 | — | 54,643 |
| Richard Rosenzweig | RSU | 4,308 | — | 49,242 |
| Richard Rosenzweig | Option | 10,266 | 38.74 | — |
| Robert Johnson | RSU | 4,143 | — | 47,354 |
| Robert Johnson | RSU | 3,011 | — | 34,415 |
| Daniel Scavilla | RSU | 3,500 | — | 40,004 |
| Andrea Frohning | RSU | 2,779 | — | 31,764 |
| Matthew Garth | RSU | 2,445 | — | 27,947 |
| Robert Johnson | Option | 417,200 | 11.18 | — |
| Robert Johnson | Option | 363,000 | 15.99 | — |
| Robert Johnson | Option | 471,400 | 12.3 | — |
| Andrea Frohning | Option | 8,166 | 38.47 | — |
| Richard Rosenzweig | Option | 25,933 | 33.28 | — |
| Richard Rosenzweig | Option | 350,100 | 15.99 | — |
The Company sets stretch goals to align with the interests of stockholders and applies effective principles and philosophies to determine and set executive compensation.
| CEO STI target (% of salary) | 135% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Frederic W. Cook & Co., Inc. |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-02 | 158,496,058 | 9,090,084 | 255,173 | 94.58% | Passed |
| 2025 | 2025-05-21 | 170,911,500 | 4,944,479 | 907,227 | 97.19% | Passed |
| 2024 | 2024-05-22 | 178,954,391 | 6,034,486 | 79,332 | 96.74% | Passed |
| 2023 | 2023-05-24 | 175,863,673 | 18,103,565 | 89,151 | 90.67% | Passed |
| 2022 | 2022-05-25 | 176,464,611 | 14,772,114 | 1,110,058 | 92.28% | Passed |
| 2021 | 2021-05-26 | 178,929,596 | 14,230,773 | 587,057 | 92.63% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-02 | 94.58%a |
| 2025 | 2025-05-21 | 97.19%b |
| 2024 | 2024-05-22 | 96.74%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will therefore have no effect on Items 1, 3, and 4.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will therefore have no effect on Items 1, 3, and 4.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will therefore have no effect on Items 1, 3, 4 and 5.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 184 : 1 |
|---|---|
| CEO total compensation | $11,005,050 |
| Median employee compensation | $59,738 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Gregory T. LucierIndependent · Board Chair · Nominating/Governance · Governance | $175,000 | $370,000 | $50,000 | $0 | $0 | $595,000 |
| Leslie F. VaronIndependent · Nominating/Governance · Audit (Chair) · Governance | 125,000 | 220,000 | 0 | 0 | 0 | 345,000 |
| Michael J. BarberIndependent · Science and Technology · Audit | 115,278 | 220,000 | 0 | 0 | 0 | 335,278 |
| Betsy D. HoldenIndependent · Compensation · Nominating/Governance (Chair) · Governance · Nominating (Chair) | 115,000 | 220,000 | 0 | 0 | 0 | 335,000 |
| Janet S. VergisIndependent · Compensation · Science and Technology (Chair) | 115,000 | 220,000 | 0 | 0 | 0 | 335,000 |
| Jonathan J. MazelskyIndependent · Compensation (Chair) · Nominating/Governance · Science and Technology · Governance | 110,000 | 220,000 | 0 | 0 | 0 | 330,000 |
| Willie A. DeeseIndependent · Compensation · Nominating/Governance · Not standing for re-election · Departed during FY | 105,000 | 220,000 | 0 | 0 | 0 | 325,000 |
| Brian T. GladdenIndependent · Audit | 100,000 | 220,000 | 0 | 0 | 0 | 320,000 |
| Clyde R. HoseinIndependent · Science and Technology · Audit | 100,000 | 220,000 | 0 | 0 | 0 | 320,000 |
| Daniel T. ScavillaEmployee director · Audit | 0 | 0 | 0 | — | 0 | 0 |
| Dorothea WenzelIndependent · Audit and Finance Committee · Departed during FY · Partial-year service | 0 | 0 | 0 | 0 | 0 | 0 |
| Brian P. McKeonIndependent · Science and Technology · Audit · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Donald J. ZurbayIndependent · Audit · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| James D. ForbesIndependent · Compensation · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Annual cash retainer | $75,000 |
|---|---|
| Annual equity retainer | $135,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | 5 times annual cash retainer |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,060,278 |
| Equity awards (grant-date value) | $2,130,000 |
| All other compensation | $0 |
| Total cost of the board | $3,190,278 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies DENTSPLY SIRONA Inc. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including DENTSPLY SIRONA Inc..
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Align Technology, Inc. | 2025 | Joseph Hogan | $1,400,000 | $16,556,872 | $0 | $1,220,100 | $19,193,988 |
| 2 | ResMed Inc. | 2026 | Michael Farrell | 1,272,895 | 9,749,468 | 3,249,907 | 1,738,857 | 16,201,649 |
| 3 | Zimmer Biomet Holdings Inc. | 2025 | Ivan Tornos | 1,281,846 | 12,000,101 | 0 | 2,420,767 | 16,106,550 |
| 4 | The Cooper Companies, Inc. | 2025 | Albert White III | 1,170,769 | 6,642,918 | 6,643,050 | 1,525,951 | 16,051,141 |
| 5 | Hologic, Inc. | 2024 | Stephen MacMillan | 1,212,628 | 9,141,468 | 2,937,477 | 1,990,413 | 15,819,261 |
| 6 | Revvity | 2025 | Prahlad Singh | 1,129,231 | 7,694,985 | 2,559,152 | 2,385,450 | 13,809,549 |
| 7 | Henry Schein, Inc. | 2025 | Stanley Bergman | 1,707,000 | 7,764,800 | 0 | 2,289,251 | 12,013,915 |
| 8 | STERIS plc | 2026 | Daniel Carestio | 1,095,707 | 4,333,951 | 4,334,251 | 1,725,007 | 11,508,522 |
| 9 | QuidelOrtho Corporation | 2025 | Brian Blaser | 1,000,000 | 8,965,822 | 0 | 1,274,500 | 11,255,782 |
| 10 | Illumina, Inc. | 2025 | Jacob Thaysen | 1,000,000 | 8,763,122 | 0 | 1,155,000 | 11,018,895 |
| 11 | Envista Holdings Corporation | 2025 | Paul Keel | 1,100,000 | 5,440,152 | 1,360,045 | 2,486,550 | 10,559,567 |
| 12 | Integra LifeSciences Holding Corporation | 2025 | Mojdeh Poul | 1,009,616 | 5,219,868 | 2,250,011 | 174,563 | 9,375,551 |
| 13 | Enovis Corporation | 2025 | Damien McDonald | 634,615 | 7,262,644 | 0 | 812,749 | 9,242,161 |
| 14 | DENTSPLY SIRONA Inc. | 2025 | Daniel Scavilla | 431,753 | 3,484,488 | 3,221,523 | 437,150 | 8,760,139 |
| 15 | West Pharmaceutical Services, Inc. | 2025 | Eric Green | 1,177,290 | 3,327,048 | 1,108,961 | 1,471,613 | 7,190,876 |
| 16 | Mettler-Toledo International Inc. | 2025 | Patrick Kaltenbach | 1,145,999 | 3,267,808 | 1,635,033 | 462,984 | 6,741,212 |
| 17 | Teleflex Incorporated | 2025 | Liam Kelly | 1,144,400 | 2,005,604 | 2,886,518 | 227,280 | 6,732,419 |
| 18 | ICU Medical, Inc. | 2025 | Vivek Jain | 775,000 | 4,500,023 | 0 | 1,162,500 | 6,452,042 |
| 19 | Avantor, Inc. | 2025 | Emmanuel Ligner | 379,297 | 2,499,990 | 2,499,998 | 330,038 | 5,895,624 |
| 20 | Patterson Companies Inc. | 2024 | Donald Zurbay | 900,001 | 3,063,124 | 1,000,000 | 813,713 | 5,895,511 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| DENTSPLY SIRONA Inc. | 66% | PSU 50 · Options 50 | No | Frederic W. Cook & Co., Inc. |
| Align Technology, Inc. | 58.1% | MSU 70 · RSU 30 | Yes — Relative Total Stockholder Return (TSR) vs. Nasdaq Composite Index | Compensia, Inc. |
| Avantor, Inc. | 56.9% | PSU 50 · Options 25 · RSU 25 | Yes — TSR Relative to Comparator Group | FW Cook |
| Enovis Corporation | 92.2% | PSU 50 · RSU 50 | Yes — Relative TSR vs. S&P 500 Health Care Equipment Select Industry Index | FW Cook |
| Envista Holdings Corporation | 151% | PSU 60 · Options 20 · RSU 20 | No | Frederic W. Cook & Co, Inc. |
| Henry Schein, Inc. | 89.3% | PSU 65 · RSU 35 | No | Pearl Meyer |
| Hologic, Inc. | 109% | PSU 50 · RSU 25 · Option 25 | No | Pearl Meyer & Partners, LLC |
| ICU Medical, Inc. | 150% | PSU 50 · RSU 50 | No | Compensia |
| Illumina, Inc. | 1155% | not disclosed | Yes — 3-year rTSR performance against select companies in the Nasdaq Biotechnology Index | Aon (Aon's Human Capital Practice, a division of Aon, plc) |
| Integra LifeSciences Holding Corporation | 40% | PSU 50 · Options 25 · RSU 25 | No | WTW |
| Mettler-Toledo International Inc. | not disclosed | not disclosed | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners |
| Patterson Companies Inc. | 72.33% | PSU 50 · Options 25 · RSU 25 | No | Semler Brossy |
| QuidelOrtho Corporation | 127% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) | Compensia |
| ResMed Inc. | not disclosed | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | FW Cook |
| Revvity | not disclosed | not disclosed | not disclosed | not disclosed |
| STERIS plc | 125.1% | RSU 50 · Options 50 | not disclosed | Frederic W. Cook & Co., Inc. |
| Teleflex Incorporated | 25.9% | Options 55 · RSU 25 · PSU 20 | Yes — Absolute TSR | FW Cook |
| The Cooper Companies, Inc. | 100.9% | Options 50 · PSU 50 | No | Compensia |
| West Pharmaceutical Services, Inc. | 100% | PSU 50 · RSU 25 · Options 25 | No | Pay Governance |
| Zimmer Biomet Holdings Inc. | 125.9% | RSU 50 · PSU 50 | Yes — Relative TSR | Semler Brossy |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Simon Campion | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Summary Compensation Table”. As printed: 10,814,258. Filing ↗machine: r9 · c27 · span 1207049–1207059 |
| 2 | Section 01, Daniel Scavilla | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Summary Compensation Table”. As printed: 8,760,139. Filing ↗machine: r5 · c27 · span 1201378–1201387 |
| 3 | Section 01, Robert Johnson | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Summary Compensation Table”. As printed: 5,706,863. Filing ↗machine: r17 · c27 · span 1218372–1218381 |
| 4 | Section 01, Richard Rosenzweig | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Summary Compensation Table”. As printed: 4,693,681. Filing ↗machine: r29 · c27 · span 1235868–1235877 |
| 5 | Section 01, Matthew Garth | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Summary Compensation Table”. As printed: 3,794,358. Filing ↗machine: r13 · c27 · span 1213592–1213601 |
| 6 | Section 01, Andrea Frohning | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Summary Compensation Table”. As printed: 2,362,959. Filing ↗machine: r21 · c27 · span 1224902–1224911 |
| 7 | Section 01, Aldo Denti | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Summary Compensation Table”. As printed: 1,507,838. Filing ↗machine: r25 · c27 · span 1230343–1230352 |
| 8 | Section 03, Robert Johnson PSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r7 · c3 · span 1106723–1106730 |
| 9 | Section 03, Andrea Frohning PSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r8 · c3 · span 1109631–1109638 |
| 10 | Section 03, Andrea Frohning RSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r8 · c9 · span 1110869–1110876 |
| 11 | Section 03, Simon Campion OPTION | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r5 · c6 · span 1101176–1101185 |
| 12 | Section 03, Simon Campion PSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r5 · c3 · span 1100555–1100564 |
| 13 | Section 03, Matthew Garth RSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r6 · c9 · span 1104876–1104883 |
| 14 | Section 03, Matthew Garth PSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r6 · c3 · span 1103636–1103645 |
| 15 | Section 03, Richard Rosenzweig PSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r10 · c3 · span 1115913–1115920 |
| 16 | Section 03, One-Time Equity PSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t210 · r11 · c9 · span 1297525–1297532 |
| 17 | Section 03, Richard Rosenzweig RSU | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r10 · c9 · span 1117345–1117352 |
| 18 | Section 03, Richard Rosenzweig OPTION | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r10 · c6 · span 1116628–1116637 |
| 19 | Section 03, Andrea Frohning OPTION | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r8 · c6 · span 1110250–1110257 |
| 20 | Section 03, Matthew Garth OPTION | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t185 · r6 · c6 · span 1104257–1104264 |
| 21 | Section 07, pay ratio | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “CEO Pay Ratio”. As printed: 184 : 1. Filing ↗ |
| 22 | Section 08, Gregory T. Lucier | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 595,000. Filing ↗machine: span 692202–692502 |
| 23 | Section 08, Leslie F. Varon | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 345,000. Filing ↗machine: span 698531–698831 |
| 24 | Section 08, Michael J. Barber | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 335,278. Filing ↗machine: span 679557–679857 |
| 25 | Section 08, Betsy D. Holden | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 335,000. Filing ↗machine: span 687986–688286 |
| 26 | Section 08, Janet S. Vergis | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 335,000. Filing ↗machine: span 700639–700939 |
| 27 | Section 08, Jonathan J. Mazelsky | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 330,000. Filing ↗machine: span 694315–694615 |
| 28 | Section 08, Willie A. Deese | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 325,000. Filing ↗machine: span 681664–681964 |
| 29 | Section 08, Brian T. Gladden | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 320,000. Filing ↗machine: span 685879–686179 |
| 30 | Section 08, Clyde R. Hosein | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 320,000. Filing ↗machine: span 690093–690393 |
| 31 | Section 08, Daniel T. Scavilla | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 32 | Section 08, Dorothea Wenzel | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 33 | Section 08, Brian P. McKeon | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 34 | Section 08, Donald J. Zurbay | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 35 | Section 08, James D. Forbes | DEF 14A | 2026-04-23 | 0000818479-26-000125 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 36 | Section 02, Daniel T. Scavilla 2026-05-22 | Form 4 | 2026-05-26 | 0000818479-26-000152 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Brian P. McKeon 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000189 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Janet S. Vergis 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000191 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Gregory T. Lucier 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000193 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Gregory T. Lucier 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000193 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Betsy D. Holden 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000186 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Michael J. Barber 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000183 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, James D. Forbes 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000184 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Brian T. Gladden 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000185 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Clyde R. Hosein 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000187 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Leslie F. Varon 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000190 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Donald J. Zurbay 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000192 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Gregory T. Lucier 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000193 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Gregory T. Lucier 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000193 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Gregory T. Lucier 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000193 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Jonathan J. Mazelsky 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000188 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Gregory T. Lucier 2026-06-03 | Form 4 | 2026-06-05 | 0000818479-26-000193 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Michael J. Barber 2026-06-11 | Form 4 | 2026-06-15 | 0000818479-26-000208 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Betsy D. Holden 2026-06-11 | Form 4 | 2026-06-15 | 0000818479-26-000209 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Jonathan J. Mazelsky 2026-06-12 | Form 4 | 2026-06-15 | 0000818479-26-000210 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Jonathan J. Mazelsky 2026-06-12 | Form 4 | 2026-06-18 | 0000818479-26-000218 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Brian P. McKeon 2026-06-12 | Form 4 | 2026-06-15 | 0000818479-26-000212 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Clyde R. Hosein 2026-06-15 | Form 4 | 2026-06-16 | 0000818479-26-000214 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Brian T. Gladden 2026-06-15 | Form 4 | 2026-06-15 | 0000818479-26-000211 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Jonathan J. Mazelsky 2026-06-30 | Form 4 | 2026-07-01 | 0000818479-26-000234 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Andrea Frohning 2026-08-07 | Form 4 | 2026-08-11 | 0000818479-26-000266 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, John C. Fortson 2026-08-10 | Form 4 | 2026-08-12 | 0000818479-26-000268 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, John C. Fortson 2026-08-10 | Form 4 | 2026-08-12 | 0000818479-26-000268 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Jonathan J. Mazelsky 2026-09-30 | Form 4 | 2026-10-02 | 0000818479-26-000271 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 06, 2026 vote | Form 8-K | 2026-06-04 | 0000818479-26-000165 | Item 5.07 · say-on-pay result. As reported: 94.58% (votes for as printed: 158,496,058). Filing ↗ |
| 66 | Section 06, 2025 vote | Form 8-K | 2025-05-22 | 0000818479-25-000080 | Item 5.07 · say-on-pay result. As reported: 97.19% (votes for as printed: 170,911,500). Filing ↗ |
| 67 | Section 06, 2024 vote | Form 8-K | 2024-05-22 | 0000818479-24-000044 | Item 5.07 · say-on-pay result. As reported: 96.74% (votes for as printed: 178,954,391). Filing ↗ |
| 68 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 69 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 70 | Section 09b board cost (computed) | Computed | — | — | Cash 1,060,278 + equity 2,130,000 + all other 0 = 3,190,278, summed across the director compensation table rows.machine: formula: Σ = 3,190,278 |
| 71 | Align Technology, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001097149-26-000023 | CEO total compensation as printed in Align Technology, Inc.'s own proxy. As printed: 19,193,988. Filing ↗machine: r2 · c42 · span 933168–933178 |
| 72 | ResMed Inc., Section 10b CEO total | DEF 14A | 2026-10-01 | 0000943819-26-000080 | CEO total compensation as printed in ResMed Inc.'s own proxy. As printed: 16,201,649. Filing ↗machine: span 1267106–1267116 |
| 73 | Zimmer Biomet Holdings Inc., Section 10b CEO total | DEF 14A | 2026-04-01 | 0001193125-26-135661 | CEO total compensation as printed in Zimmer Biomet Holdings Inc.'s own proxy. As printed: 16,106,550. Filing ↗machine: t111 · r3 · c16 · span 1895785–1895795 |
| 74 | The Cooper Companies, Inc., Section 10b CEO total | DEF 14A | 2026-02-24 | 0001628280-26-011110 | CEO total compensation as printed in The Cooper Companies, Inc.'s own proxy. As printed: 16,051,141. Filing ↗machine: t120 · r3 · c14 · span 744904–744914 |
| 75 | Hologic, Inc., Section 10b CEO total | DEF 14A | 2025-01-16 | 0001140361-25-001287 | CEO total compensation as printed in Hologic, Inc.'s own proxy. As printed: 15,819,261. Filing ↗machine: r2 · c25 · span 1549664–1549674 |
| 76 | Revvity, Section 10b CEO total | DEF 14A | 2026-03-16 | 0001193125-26-107266 | CEO total compensation as printed in Revvity's own proxy. As printed: 13,809,549. Filing ↗machine: r3 · c39 · span 751285–751295 |
| 77 | Henry Schein, Inc., Section 10b CEO total | DEF 14A | 2026-04-08 | 0001193125-26-146317 | CEO total compensation as printed in Henry Schein, Inc.'s own proxy. As printed: 12,013,915. Filing ↗machine: t221 · r3 · c35 · span 671366–671376 |
| 78 | STERIS plc, Section 10b CEO total | DEF 14A | 2026-06-11 | 0001193125-26-267599 | CEO total compensation as printed in STERIS plc's own proxy. As printed: 11,508,522. Filing ↗machine: t172 · r6 · c34 · span 820590–820600 |
| 79 | QuidelOrtho Corporation, Section 10b CEO total | DEF 14A | 2026-04-27 | 0001906324-26-000018 | CEO total compensation as printed in QuidelOrtho Corporation's own proxy. As printed: 11,255,782. Filing ↗machine: r4 · c24 · span 760612–760622 |
| 80 | Illumina, Inc., Section 10b CEO total | DEF 14A | 2026-04-09 | 0001193125-26-149669 | CEO total compensation as printed in Illumina, Inc.'s own proxy. As printed: 11,018,895. Filing ↗machine: r4 · c14 · span 728526–728536 |
| 81 | Envista Holdings Corporation, Section 10b CEO total | DEF 14A | 2026-04-07 | 0001757073-26-000031 | CEO total compensation as printed in Envista Holdings Corporation's own proxy. As printed: 10,559,567. Filing ↗machine: span 692624–692634 |
| 82 | Integra LifeSciences Holding Corporation, Section 10b CEO total | DEF 14A | 2026-04-06 | 0000917520-26-000015 | CEO total compensation as printed in Integra LifeSciences Holding Corporation's own proxy. As printed: 9,375,551. Filing ↗machine: r2 · c30 · span 880204–880213 |
| 83 | Enovis Corporation, Section 10b CEO total | DEF 14A | 2026-04-06 | 0001493152-26-015302 | CEO total compensation as printed in Enovis Corporation's own proxy. As printed: 9,242,161. Filing ↗machine: r1 · c37 · span 876874–876883 |
| 84 | DENTSPLY SIRONA Inc. (subject), Section 10b CEO total | DEF 14A | 2026-04-23 | 0000818479-26-000125 | CEO total compensation as printed in DENTSPLY SIRONA Inc.'s own proxy. As printed: 8,760,139. Filing ↗machine: r5 · c27 · span 1201378–1201387 |
| 85 | West Pharmaceutical Services, Inc., Section 10b CEO total | DEF 14A | 2026-03-12 | 0001104659-26-026778 | CEO total compensation as printed in West Pharmaceutical Services, Inc.'s own proxy. As printed: 7,190,876. Filing ↗machine: t165 · r7 · c18 · span 1241781–1241790 |
| 86 | Mettler-Toledo International Inc., Section 10b CEO total | DEF 14A | 2026-03-18 | 0001174947-26-000389 | CEO total compensation as printed in Mettler-Toledo International Inc.'s own proxy. As printed: 6,741,212. Filing ↗machine: r2 · c7 · span 643529–643538 |
| 87 | Teleflex Incorporated, Section 10b CEO total | DEF 14A | 2026-04-13 | 0000096943-26-000039 | CEO total compensation as printed in Teleflex Incorporated's own proxy. As printed: 6,732,419. Filing ↗machine: span 558736–558745 |
| 88 | ICU Medical, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0000883984-26-000019 | CEO total compensation as printed in ICU Medical, Inc.'s own proxy. As printed: 6,452,042. Filing ↗machine: r2 · c24 · span 432290–432299 |
| 89 | Avantor, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0001628280-26-021572 | CEO total compensation as printed in Avantor, Inc.'s own proxy. As printed: 5,895,624. Filing ↗machine: r3 · c9 · span 2130032–2130041 |
| 90 | Patterson Companies Inc., Section 10b CEO total | DEF 14A | 2024-08-02 | 0001140361-24-035443 | CEO total compensation as printed in Patterson Companies Inc.'s own proxy. As printed: 5,895,511. Filing ↗machine: r1 · c22 · span 1037370–1037379 |
| 91 | Section 10a, The Cooper Companies, Inc. reciprocity | DEF 14A | — | 0001628280-26-011110 | The Cooper Companies, Inc. names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 92 | Section 10a, Henry Schein, Inc. reciprocity | DEF 14A | — | 0001193125-26-146317 | Henry Schein, Inc. names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 93 | Section 10a, STERIS plc reciprocity | DEF 14A | — | 0001193125-26-267599 | STERIS plc names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 94 | Section 10a, Envista Holdings Corporation reciprocity | DEF 14A | — | 0001757073-26-000031 | Envista Holdings Corporation names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 95 | Section 10a, West Pharmaceutical Services, Inc. reciprocity | DEF 14A | — | 0001104659-26-026778 | West Pharmaceutical Services, Inc. names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 96 | Section 10a, Zimmer Biomet Holdings Inc. reciprocity | DEF 14A | — | 0001193125-26-135661 | Zimmer Biomet Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include DENTSPLY SIRONA Inc.. Filing ↗ |
| 97 | Section 10a, Avantor, Inc. reciprocity | DEF 14A | — | 0001628280-26-021572 | Avantor, Inc.'s most recent proxy was read; its disclosed peer group does not include DENTSPLY SIRONA Inc.. Filing ↗ |
| 98 | Section 10a, Integra LifeSciences Holding Corporation reciprocity | DEF 14A | — | 0000917520-26-000015 | Integra LifeSciences Holding Corporation's most recent proxy was read; its disclosed peer group does not include DENTSPLY SIRONA Inc.. Filing ↗ |
| 99 | Section 10a, Align Technology, Inc. reciprocity | DEF 14A | — | 0001097149-26-000023 | Align Technology, Inc. names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 100 | Section 10a, Hologic, Inc. reciprocity | DEF 14A | — | 0001140361-25-001287 | Hologic, Inc. names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 101 | Section 10a, ICU Medical, Inc. reciprocity | DEF 14A | — | 0000883984-26-000019 | ICU Medical, Inc.'s most recent proxy was read; its disclosed peer group does not include DENTSPLY SIRONA Inc.. Filing ↗ |
| 102 | Section 10a, Teleflex Incorporated reciprocity | DEF 14A | — | 0000096943-26-000039 | Teleflex Incorporated names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 103 | Section 10a, Mettler-Toledo International Inc. reciprocity | DEF 14A | — | 0001174947-26-000389 | Mettler-Toledo International Inc.'s most recent proxy was read; its disclosed peer group does not include DENTSPLY SIRONA Inc.. Filing ↗ |
| 104 | Section 10a, Patterson Companies Inc. reciprocity | DEF 14A | — | 0001140361-24-035443 | Patterson Companies Inc. names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 105 | Section 10a, QuidelOrtho Corporation reciprocity | DEF 14A | — | 0001906324-26-000018 | QuidelOrtho Corporation names DENTSPLY SIRONA Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 106 | Section 10a, ResMed Inc. reciprocity | DEF 14A | — | 0000943819-26-000080 | ResMed Inc.'s most recent proxy was read; its disclosed peer group does not include DENTSPLY SIRONA Inc.. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the DENTSPLY SIRONA Inc. Executive Compensation Report
$1,500